APA (7th ed.) Citation

WP, J., ME, F., R, S., & KB, C. (2026). Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma. Molecular therapy. Oncology, 34(1), 201169. https://doi.org/10.1016/j.omton.2026.201169

Chicago Style (17th ed.) Citation

WP, Jayne, Freilich ME, Solanki R, and Challagundla KB. "Reprogramming CXCL10-mediated NK Cell Trafficking to Enhance Immunotherapy in Osteosarcoma." Molecular Therapy. Oncology 34, no. 1 (2026): 201169. https://doi.org/10.1016/j.omton.2026.201169.

MLA (9th ed.) Citation

WP, Jayne, et al. "Reprogramming CXCL10-mediated NK Cell Trafficking to Enhance Immunotherapy in Osteosarcoma." Molecular Therapy. Oncology, vol. 34, no. 1, 2026, p. 201169, https://doi.org/10.1016/j.omton.2026.201169.